The Board has approved the appointment of Mr. Sanjay Patel as an Independent director, re-app of MR. Rajendra R Shah and approved cessation of Mr Bharat Mehta
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mercury Laboratories' board approved audited FY25 results with revenue of Rs 75.10 crore (vs Rs 75.56 crore last year) and net profit dropping sharply to Rs 3.14 crore from Rs 5.65 crore. A final dividend of Rs 3.50 per share (35%) has been recommended, subject to shareholder approval. The board appointed Mr. Sanjay Patel as Non-Executive Independent Director and Chairman for 5 years, and re-appointed existing founder Mr. Rajendra Shah as Managing Director for another 3 years from April 2026. Independent Director Mr. Bharat Mehta ceased on completion of his second term. New Secretarial, Internal, and Cost Auditors were also appointed. The 44th AGM is scheduled for August 13, 2025.
Sharp ~44% drop in annual profit is a concern despite stable revenue, though the final dividend signals management's confidence in cash flows. Board continuity is maintained with founder Rajendra Shah staying on as MD, while a new Independent Chairman brings fresh oversight. Shareholders should watch margin recovery in coming quarters.